Comments
Pfizer says on lookout for mid-size drug deals
02.05.2012. | (Reuters) - Pfizer Inc, which last week agreed to sell its baby formula business for almost $12 billion, is on the hunt for companies with promising new treatments for diabetes, cancer and neurological conditions, and willing to spend $4 billion or more apiece, company Chief Executive Ian Read said....
